Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency


Creative Commons License

Lévy R., Gothe F., Momenilandi M., Magg T., Materna M., Peters P., ...Daha Fazla

JOURNAL OF EXPERIMENTAL MEDICINE, cilt.220, sa.2, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 220 Sayı: 2
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1084/jem.20220275
  • Dergi Adı: JOURNAL OF EXPERIMENTAL MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, Chemical Abstracts Core, EMBASE, MEDLINE, Veterinary Science Database
  • Marmara Üniversitesi Adresli: Evet

Özet

Inherited CARMIL2 deficiency underlies infections, EBV+ smooth muscle tumors, and mucocutaneous inflammation. CARMIL2 deficiency impairs CD28 signaling only partially in T cells. The comparison of CARMIL2 and CD28 deficiency in humans suggests that CARMIL2 governs immunological pathways beyond CD28.